| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.43 | 0.009 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |